PROG Reversal A bullish reversal propelled by a bullish divergence on the MACD
Price will likely continue up to the top of the wedge, and then continue the downtrend.
This is just a temporary bullish time.
Progenity
Progenity, Inc. (PROG) 1H Trading Analysis (TA)1H Chart, Progenity, Inc. ( PROG ) on February 22 2022, the signals are on their third intent to pierce far below the MACD; The RSI signal is also below 30 showing a shy movement north east; Inside the chart the price is far below the 100/200 MA signals but still over the last too deeps before the last 100/200 MA signals piercing on FEB 03, if the price finds support enough on the $1.40 could make it bounce back north toward the 100/200 MA signals, which is the optimistic approach, but remember "In this business if you're good, you're right six times out of ten. You're never going to be right nine times out of ten. I've found that when the market's going down and you buy funds wisely, at some point in the future you will be happy. You won't get there by reading 'Now is the time to buy.'". At this time this ticker has a Volume of 10.8M, with Average Volume (10) of 12.11M and a Market Cap of 227.6M. Good Luck!
Gráfico 1H, Progenity, Inc. ( PROG ) el 22 de febrero de 2022, las señales están en su tercer intento de cruzar muy por debajo del MACD; La señal RSI también está por debajo de 30 mostrando un tímido movimiento hacia el noreste; Dentro del gráfico, el precio está muy por debajo de las señales de 100/200 MA, pero aún está por encima de las últimas señales bajas antes de que las últimas señales de 100/200 MA se cruzaran el 3 de febrero, si el precio encuentra suficiente soporte en $1.40 podría hacer que rebote hacia el norte hacia las señales 100/200 MA, que es el enfoque optimista, pero recuerde "En este negocio, si es bueno, tiene razón seis veces sobre diez. Nunca tendrá razón nueve veces sobre diez. He descubierto que cuando el mercado baja y compro fondos sabiamente, en algún momento en el futuro se siente la felicidad. Pero para llegar a ese momento nunca leerá una señal que diga: "Ahora es el momento de comprar". En este momento este ticker tiene un Volumen de 10,8M, con un Volumen Promedio (10) de 12,11M y una Capitalización de Mercado de 227,6M. ¡Buena suerte!
“I believe in analysis and not forecasting.” / "Creo en el análisis y no en el pronóstico".
REMEMBER : I am not a financial adviser nor is any content in this article presented as financial advice. The information provided in this blog post and any other posts that I make and any accompanying material is for informational purposes only. It should not be considered financial or investment advice of any kind. One should consult with a financial or investment professional to determine what may be best for your individual needs. RECUERDE : No soy un asesor financiero y el contenido de este artículo no se presenta como asesoramiento financiero. La información provista en esta publicación de blog y cualquier otra publicación que haga y cualquier material que la acompañe es solo para fines informativos. No debe considerarse asesoramiento financiero o de inversión de ningún tipo. Se debe consultar con un profesional financiero o de inversiones para determinar qué es lo mejor para sus necesidades individuales.
$PROG price breakout we will see a price momentum shift if we hold our support , then we will see a first test at 1.80$ where we meet our first resistant .
$PROG PRICE ALERT we starting to make higher lows, to confirm the reversal and price pump up we should hold above the 1.43$, then we will see a test for 2 resistant areas , first at 1.80$, second at 2.11$.
Progenity (NASDAQ: $PROG) Looks Like Another Easy Winner! 🏆Progenity, Inc., a biotechnology company, provides develops and commercializes molecular testing products in the United States. It offers Innatal, a noninvasive prenatal screening test offered to women early in pregnancy to screen for chromosome abnormalities, such as down syndrome, trisomy 18, trisomy 13, and sex chromosome disorders through the analysis of cell-free DNA; Preparent that screens for carrier status of hereditary diseases prior to or early in pregnancy; and Riscover, a hereditary cancer screen that analyzes 31 genes associated with inherited risk of 12 types of cancers, including the BRCA1/2 genes for hereditary breast, ovarian, colorectal, endometrial, pancreatic, and other cancer syndromes, as well as for the five genes associated with Lynch syndrome. The company also provides Resura, a noninvasive prenatal test for families at risk for rare single gene disorders; and Preecludia, a preeclampsia rule-out test. In addition, it offers anatomic and molecular pathology tests, and COVID-19 PCR testing services, as well as test products that includes chromosomal microarray for pregnancy loss, which evaluates the genetic cause of miscarriage; maternal serum screening for chromosomal disorders; and preimplantation genetic testing for use with artificial reproductive technologies. Further, the company develops therapeutic solutions for gastrointestinal-related disorders, such as PGN-001, PGN-300, PGN-600, and PGN-OB2. It also owns and operates laboratory. Progenity, Inc. was formerly known as Ascendant MDX, Inc. and changed its name to Progenity, Inc. in November 2013. The company was founded in 2010 and is headquartered in San Diego, California.
$PROG to break out of algo cycle Monday? $8+ PTProgenity has been in the same cyclic pattern since late September and has followed a trend carefully. The last high of $6.20 formed a rising wedge which is looking close to a breakout.
The MACD and RSI indicate a reversal, as well as the 20/50/100/200 EMA (not shown on the chart). The trend has not fallen below the 200 day EMA + the Fibonacci Time Zone indicates a possible reversal coming. If the trend breaks out of the wedge the $4.80 and $5.10 levels will be a tough retest, and it may not hold - but if it is able to break past a new 6 month high looks promising.
My theory is that if this coil explodes past the $8-10 level (counting on catalysts + buying pressure) that the algo cycle will end as shorts cover their positions.
PROG shortRSI is at overbought conditions. However the trend seems to be strong therefore we expect continuation toward the next resistance which would be our entry price for short position. The target as in the chart.
No financial advice
PROG Progenity Price TargetIf you haven`t bought PROG at my first call, at 1.29usd:
Then you should know that Piper Sandler has a $5 price target for it!
We are not there yet. We still have upside potential on this one!
Progenity moving South. PROGCheck out that massive divergence after a few unusually quick in succession zigs. The momentum drew lower peaks each time on the a new high. Directional movement is also indicating a downward move.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
PROG Progenity Price TargetsProgenity is a biotechnology company wich provides, develops and commercializes molecular testing products in the United States.
ON 7/29/2021 Steven Mah from Piper Sandler brokerage Boosted the Price Target to Overweight from $3.00 to $5.00
My price target is the 2.5usd resistance.
52 Week Range 0.65 - 9.56
Don`t forget last month`s 40mil offering at $1.49 with warrants at 1usd!
